Avalon Globocare Corp is a commercial-stage company dedicated to developing and delivering innovative, transformative, precision diagnostics and clinical laboratory services..
Avalon GloboCare News
FREEHOLD, N.J., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of innovative precisio...
Patent for Multiple Novel QTY-Code Modified Cytokine and Chemokine Protein Receptor MoleculesFREEHOLD, N.J., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare...
Avalon GloboCare Corp (NASDAQ: ALBT) announced that Laboratory Services MSO (LSM) is now offering an in-house laboratory-developed test to detect tuberculosis u...
New Proprietary Testing Method Makes Tuberculosis Diagnosis Easier and Faster New Test Method Expected to Generate Revenue in 2023 FREEHOLD, N.J., Aug. 30, 2023...
New Wholly Owned Lab “Veritas Laboratory” of Arizona, Anticipated to Generate Revenue in 2023 Engages Former Congressman Barry M. Goldwater Jr. To Expand In...
Avalon GloboCare ( NASDAQ:ALBT ) Second Quarter 2023 Results Key Financial Results Net loss: US$2.54m (loss widened by......
DE Laboratory in Texas Performs 1,500 Lab Tests Per Month with Focus on Toxicology and Wellness Testing; Expansion UnderwayFREEHOLD, N.J., July 24, 2023 (GLOBE ...
MSA Signed with GeneX Laboratory, an In-Network Laboratory Licensed in Multiple States Including Medicare and Medicaid Laboratory Services MSO will be the Exclu...
Company Continues to Implement Major Change in Strategy Focused on Acquiring and Operating Accretive Revenue Generating Laboratories and Related Commercialized ...
Disclaimer: